Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study

NCT02402244 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT02402244
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02402244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Project: EveryChild Protocol: A Registry, Eligibility Screening, Biology and Outcome Study
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Recruiting
Start date
November 3, 2015
Completion date
December 31, 2030
Enrollment
75,000 (estimated)
Sites
279

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal gland pheochromocytoma, carcinoma in situ, central nervous system neoplasm, childhood immature teratoma, childhood kidney neoplasm, childhood langerhans cell histiocytosis, childhood mature teratoma, congenital mesoblastic nephroma, desmoid fibromatosis, ganglioneuroma, lymphoproliferative disorder, malignant neoplasm, malignant solid neoplasm, melanocytic neoplasm, myeloproliferative neoplasm, neoplasm of uncertain malignant potential, neuroendocrine neoplasm, stromal neoplasm